By Monk Tom 

INSULIN RESISTANCE IN THE LIVER DUE TO SUCRALOSE

Key message of the study:
Sucralose is an artificial sweetener that replaces sugar without calories. With regular consumption, it can reduce insulin sensitivity in the liver via the ERK1/2 signaling pathway. Normally, insulin regulates blood sugar levels by stimulating the liver to absorb and store glucose. Sucralose can disrupt this signal transmission, which in the long term leads to insulin resistance – a risk factor for metabolic diseases.  

What is Insulin?
Insulin is a hormone produced by the pancreas. It regulates blood sugar levels by:
1. Promoting glucose uptake into muscle and fat cells.
2. Supporting the storage of glucose in the liver as glycogen.
3. Inhibiting glucose production in the liver (gluconeogenesis). 

 The Role of the Liver in Glucose Metabolism
The liver plays a central role in regulating blood sugar:
• After a meal: When blood sugar levels rise, insulin signals the liver to store excess glucose as glycogen.
• During fasting or between meals: When blood sugar levels drop, the liver produces glucose from stored glycogen (glycogenolysis) or builds new glucose from precursors like amino acids (gluconeogenesis). Insulin Resistance in the Liver – Explained Simply: Insulin resistance in the liver describes a condition where liver cells become less sensitive to the hormone insulin.
Normally, insulin ensures that the liver reduces glucose production (release of sugar into the blood) when blood sugar levels are sufficiently high. In insulin resistance, this regulation no longer works properly:
1. What normally happens? After eating, insulin signals the liver: "There’s enough sugar in the blood – stop glucose production!" The liver complies and stores sugar as glycogen.
2. In insulin resistance: The liver ignores the insulin signal. Despite the presence of insulin, it continues to release glucose into the blood, unnecessarily raising blood sugar levels. This is a major issue in type 2 diabetes. 

 Consequences:
• Chronically high blood sugar (leads to diabetes).
• Fatty liver disease (hepatic steatosis).
• Increased risk of cardiovascular diseases. 

What Happens in Insulin Resistance in the Liver?
In insulin resistance in the liver, this regulation no longer works properly. The liver becomes less responsive to the insulin signal, leading to the following problems:
1. Increased glucose production:
• Despite high insulin levels, the liver cannot adequately inhibit gluconeogenesis.
• This results in increased glucose release into the bloodstream, even when the body already has sufficient energy.
2. Reduced glycogen storage:
• The liver stores less glucose as glycogen because it poorly responds to the insulin signal.
3. Disruption of lipid metabolism:
• Insulin resistance also impairs fat metabolism processes in the liver. This can lead to the accumulation of fatty acids and the development of non-alcoholic fatty liver disease (NAFLD).
4. Systemic effects:
• An insulin-resistant liver contributes to the development of systemic insulin resistance syndrome, affecting other tissues such as muscles and adipose tissue.
• Over the long term, this can lead to type 2 diabetes, metabolic syndrome, and cardiovascular diseases. 

 How Does Insulin Resistance in the Liver Develop?
The exact mechanisms are complex and involve several factors:
1. Chronic inflammation:
• Excess fat tissue (obesity) releases pro-inflammatory messengers (cytokines) that reduce insulin sensitivity.
2. Endoplasmic reticulum (ER) stress:
• Overloading the ER in liver cells can trigger stress responses that disrupt insulin pathways.
3. Activation of signaling pathways:
• The ERK1/2 signaling pathway, described in the study on sucralose, plays an important role. Its activation can block insulin receptor signal transduction. 4. Increased free fatty acids:
• Free fatty acids from adipose tissue can cause lipotoxicity in the liver and further reduce insulin sensitivity.
5. Genetic factors:
• Some people have a genetic predisposition for insulin resistance.

Symptoms and Consequences of Insulin Resistance in the Liver
Insulin resistance in the liver often develops gradually and remains unnoticed for a long time. Possible symptoms and consequences include:
• Elevated blood sugar levels (hyperglycemia).
• Fatigue and lack of energy.
• Weight gain, especially around the abdomen.
• Elevated triglyceride levels in the blood.
• Development of type 2 diabetes.
• Non-alcoholic fatty liver disease (NAFLD).
• Increased risk of cardiovascular diseases. 

How Can Insulin Resistance in the Liver Be Improved?
Fortunately, there are several strategies to combat insulin resistance in the liver:
1. Weight loss:
• Even moderate weight loss can significantly improve the liver’s insulin sensitivity.
2. Dietary changes:
• Reduction of sugar and refined carbohydrates.
• More fiber, whole grains, and healthy fats.
• Avoidance of artificial sweeteners like sucralose, which studies show worsen insulin resistance.
3. Exercise:
• Regular physical activity improves insulin sensitivity in muscles and the liver.
4. Reduction of inflammation:
• Omega-3 fatty acids and antioxidants can help reduce inflammation.
5. Avoidance of risk factors:
• Smoking, excessive alcohol consumption, and unhealthy lifestyle habits should be avoided. 

What Is the ERK1/2 Signaling Pathway?
ERK stands for Extracellular Signal-Regulated Kinase, and it is part of a larger family of protein kinases known as MAPK signaling pathways (Mitogen-Activated Protein Kinase).
The ERK1/2 signaling pathway is one of the most important MAPK pathways and is often activated by external signals, such as growth factors, hormones, or other stimuli. 

How Does the ERK1/2 Signaling Pathway Work?
1. Activation by external signals:
• When a cell receives an external signal (e.g., through a receptor on the cell surface), a cascade of events is triggered.
• A common trigger is the activation of a tyrosine kinase receptor (e.g., insulin receptor) or a G-protein-coupled receptor (GPCR).
2. Signal transmission through protein kinases:
• The signal is transmitted through a series of protein kinases:
• Raf (a serine/threonine kinase) is activated.
• Raf activates MEK1/2 (MAPK/ERK kinase).
• MEK1/2 then phosphorylates ERK1/2.
3. Target proteins and cellular effects:
• Phosphorylated (active) ERK1/2 migrates to the cell nucleus, where it influences various target proteins, including transcription factors.
• This leads to changes in gene expression, which in turn can affect cell function:
• Promotion of cell growth and division.
• Regulation of metabolism.
• Response to stress or inflammation. 

 Why Is the ERK1/2 Signaling Pathway Relevant to Insulin Resistance?
The ERK1/2 signaling pathway is directly related to the development of insulin resistance, particularly in the liver. Here are the key mechanisms:
1. Inhibition of insulin signal transmission:
• Insulin normally binds to its receptor on the cell surface and activates a cascade of signals that ultimately lead to glucose uptake into the cells.
• When the ERK1/2 signaling pathway is overactivated (e.g., by sucralose), it can disrupt insulin signal transmission.
• Specifically, ERK1/2 inhibits the activation of Akt (also known as Protein Kinase B), a key enzyme in the insulin signaling pathway. Akt is responsible for promoting glucose uptake and inhibiting gluconeogenesis (the production of glucose in the liver).
2. Increased lipolysis and inflammation:
• Overactivated ERK1/2 signals can also promote lipolysis (the breakdown of fat).
• Free fatty acids released during lipolysis can trigger inflammatory responses, which in turn contribute to insulin resistance.
• Additionally, ERK1/2 activates the expression of inflammatory cytokines, further worsening insulin sensitivity.
3. Connection to metabolic diseases:
• Chronic activation of the ERK1/2 signaling pathway is associated with various metabolic diseases, including type 2 diabetes, fatty liver, and obesity.
• In people with overweight or obesity, the ERK1/2 signaling pathway is often overactive, further exacerbating insulin resistance. 

How Does Sucralose Affect the ERK1/2 Signaling Pathway?
The study shows that sucralose activates the ERK1/2 signaling pathway, leading to the development of insulin resistance. Here are the key steps:
1. Activation through T1R3 receptor:
• Sucralose binds to the T1R3 sweet taste receptor, a taste receptor also expressed in the liver.
• This binding triggers an intracellular signaling cascade that leads to the activation of ERK1/2.
2. Phosphorylation of ERK1/2:
• Within minutes of exposure to sucralose, the phosphorylation of ERK1/2 increases in the cells.
• This leads to the activation of the ERK1/2 signaling pathway.
3. Disruption of insulin signal transmission:
• Activated ERK1/2 inhibits insulin-induced activation of Akt.
• This reduces insulin sensitivity, leading to decreased glucose uptake and increased gluconeogenesis in the liver.
4. Reversibility through ERK1/2 inhibition:
• The study shows that blocking ERK1/2 (e.g., using the inhibitor U0126) can reverse the negative effects of sucralose on insulin sensitivity.
• This underscores the central role of the ERK1/2 signaling pathway in sucralose-induced insulin resistance. 

Why Is This Important?
The ERK1/2 signaling pathway is a critical mediator in the development of insulin resistance, particularly in the liver. The study shows that long-term consumption of sucralose activates this signaling pathway, leading to reduced insulin sensitivity. This occurs independently of calorie intake and can have serious health consequences, such as the development of type 2 diabetes and fatty liver. The findings highlight the importance of mindful nutrition and suggest that artificial sweeteners like sucralose are not harmless, as previously assumed. They also indicate that further research is needed to better understand the long-term effects of these substances. 

Conclusion
Insulin resistance in the liver is a key factor in the development of metabolic diseases such as type 2 diabetes and fatty liver. It arises from a combination of genetic, dietary, and lifestyle factors. Targeted changes in diet, regular exercise, and, if necessary, medication can restore the liver’s insulin sensitivity.
The study on sucralose shows that even seemingly harmless substances like artificial sweeteners can negatively affect insulin sensitivity, underscoring the importance of mindful nutrition. The study demonstrates for the first time a clear causal link between long-term sucralose consumption and the development of insulin resistance in the liver. This has important implications for understanding the health effects of artificial sweeteners. The results suggest that even calorie-free sweeteners like sucralose can have significant metabolic effects, warranting closer examination of their role in the diet.

(STUDY PDF)